• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

入院时的高血糖症可预测行经皮冠状动脉介入治疗的急性 ST 段抬高型心肌梗死患者的梗死面积更大。

Hyperglycemia on admission predicts larger infarct size in patients undergoing percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.

机构信息

Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Gray/Bigelow 800, Boston, MA 02114, USA.

出版信息

Diabetes Res Clin Pract. 2010 Apr;88(1):97-102. doi: 10.1016/j.diabres.2010.01.001. Epub 2010 Jan 18.

DOI:10.1016/j.diabres.2010.01.001
PMID:20083319
Abstract

AIMS

To determine if hyperglycemia on admission correlates to infarct size measured by single-photon emission computed tomography (SPECT) in patients with acute ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI).

METHODS

We evaluated 347 STEMI patients who underwent primary PCI. Infarct size was determined by SPECT on Day 5. The population was divided into: hyperglycemia (glycemia on admission >11mmol/L) or non-hyperglycemia (<or=11mmol/L) regardless of diabetic status.

RESULTS

61 (17.6%) patients presented with hyperglycemia on admission. There were no significant differences in baseline characteristics or in PCI characteristics between the two groups. Final TIMI 3 flow was achieved in 81.7% of patients with hyperglycemia vs 85.7% of patients with non-hyperglycemia (p=0.43). The infarct size was larger in the hyperglycemia group (6 [2-14]% vs 8.5 [3-18.25]%; p=0.016). A multivariate linear regression analysis showed that hyperglycemia on admission was an independent predictor of infarct size at Day 5 post-MI (p=0.004).

CONCLUSION

In patients with STEMI treated with primary PCI, hyperglycemia on admission is associated with larger infarct size determined by SPECT.

摘要

目的

确定入院时的高血糖是否与接受直接经皮冠状动脉介入治疗(PCI)的急性 ST 段抬高型心肌梗死(STEMI)患者的单光子发射计算机断层扫描(SPECT)测量的梗死面积相关。

方法

我们评估了 347 例接受直接 PCI 的 STEMI 患者。梗死面积通过 SPECT 在第 5 天确定。人群分为:高血糖(入院时血糖>11mmol/L)或非高血糖(<=11mmol/L),无论是否合并糖尿病。

结果

61 例(17.6%)患者入院时存在高血糖。两组患者的基线特征或 PCI 特征均无显著差异。高血糖组终末 TIMI 3 血流的获得率为 81.7%,而非高血糖组为 85.7%(p=0.43)。高血糖组的梗死面积较大(6 [2-14]% vs 8.5 [3-18.25]%;p=0.016)。多变量线性回归分析显示,入院时的高血糖是心肌梗死后第 5 天 SPECT 测量的梗死面积的独立预测因子(p=0.004)。

结论

在接受直接 PCI 治疗的 STEMI 患者中,入院时的高血糖与 SPECT 测定的更大梗死面积相关。

相似文献

1
Hyperglycemia on admission predicts larger infarct size in patients undergoing percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.入院时的高血糖症可预测行经皮冠状动脉介入治疗的急性 ST 段抬高型心肌梗死患者的梗死面积更大。
Diabetes Res Clin Pract. 2010 Apr;88(1):97-102. doi: 10.1016/j.diabres.2010.01.001. Epub 2010 Jan 18.
2
Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial.pexelizumab 对行直接经皮冠状动脉介入治疗的急性心肌梗死患者的梗死面积的影响:APEPI-AMI 试验延迟增强心脏磁共振子研究。
JACC Cardiovasc Imaging. 2010 Jan;3(1):52-60. doi: 10.1016/j.jcmg.2009.09.014. Epub 2010 Jan 12.
3
Relationship between TIMI frame count and admission glucose values in acute ST elevation myocardial infarction patients who underwent successful primary percutaneous intervention.成功接受直接经皮冠状动脉介入治疗的急性ST段抬高型心肌梗死患者中,心肌梗死溶栓治疗(TIMI)帧数与入院血糖值的关系。
Anadolu Kardiyol Derg. 2011 May;11(3):213-7. doi: 10.5152/akd.2011.055. Epub 2011 Mar 21.
4
Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.心脏生物标志物在预测ST段抬高型心肌梗死直接经皮冠状动脉介入治疗后的梗死面积、左心室功能及临床结局中的作用。
JACC Cardiovasc Interv. 2008 Aug;1(4):415-23. doi: 10.1016/j.jcin.2008.04.010.
5
Admission hyperglycemia and TIMI frame count in primary percutaneous coronary intervention.直接经皮冠状动脉介入治疗中的入院高血糖与 TIMI 帧数。
Angiology. 2012 Jul;63(5):325-9. doi: 10.1177/0003319711418957. Epub 2011 Aug 25.
6
Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.血浆B型利钠肽水平可预测急性ST段抬高型心肌梗死患者接受直接经皮冠状动脉介入治疗时的心肌组织灌注情况。
Coron Artery Dis. 2011;22(6):405-10. doi: 10.1097/MCA.0b013e3283487dac.
7
Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study.经皮冠状动脉介入联合溶栓性血栓切除术减少急性心肌梗死梗死面积:一项多中心随机研究的30天结果
J Am Coll Cardiol. 2006 Jul 18;48(2):244-52. doi: 10.1016/j.jacc.2006.03.044. Epub 2006 Jun 23.
8
Effects of atorvastatin pretreatment on infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.阿托伐他汀预处理对行直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者梗死面积的影响。
Am Heart J. 2011 Dec;162(6):1026-33. doi: 10.1016/j.ahj.2011.08.011.
9
Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO (Alliance for Myocardial Infarction Care Optimization) Registry.与单独进行直接经皮冠状动脉介入治疗相比,降低剂量纤溶加速ST段抬高型心肌梗死治疗并联合紧急经皮冠状动脉介入治疗的效果:AMICO(心肌梗死护理优化联盟)注册研究结果
JACC Cardiovasc Interv. 2008 Oct;1(5):504-10. doi: 10.1016/j.jcin.2008.06.009.
10
ST-segment analysis to predict infarct size and functional outcome in acute myocardial infarction treated with primary coronary intervention and adjunctive abciximab therapy.ST段分析预测接受直接冠状动脉介入治疗及辅助阿昔单抗治疗的急性心肌梗死患者的梗死面积和功能结局。
Am J Cardiol. 2006 Jan 1;97(1):48-54. doi: 10.1016/j.amjcard.2005.07.109. Epub 2005 Nov 8.

引用本文的文献

1
Impact of Acute Insulin Resistance on Myocardial Blush in Non-Diabetic Patients Undergoing Primary Percutaneous Coronary Intervention.急性胰岛素抵抗对接受直接经皮冠状动脉介入治疗的非糖尿病患者心肌灌注的影响
Front Cardiovasc Med. 2021 May 10;8:647366. doi: 10.3389/fcvm.2021.647366. eCollection 2021.
2
Hyperglycemia, inflammatory response and infarct size in obstructive acute myocardial infarction and MINOCA.梗阻性急性心肌梗死和 MINOCA 中的高血糖、炎症反应和梗死面积。
Cardiovasc Diabetol. 2021 Feb 2;20(1):33. doi: 10.1186/s12933-021-01222-9.
3
Glycemic Control in Coronary Revascularization.
冠状动脉血运重建中的血糖控制
Curr Treat Options Cardiovasc Med. 2016 Feb;18(2):12. doi: 10.1007/s11936-015-0434-6.
4
Admission glucose and left ventricular systolic function in non-diabetic patients with acute myocardial infarction.非糖尿病急性心肌梗死患者的入院血糖与左心室收缩功能
Heart Vessels. 2016 Mar;31(3):298-307. doi: 10.1007/s00380-014-0610-8. Epub 2014 Dec 25.
5
Fasting hyperglycemia increases in-hospital mortality risk in nondiabetic female patients with acute myocardial infarction: a retrospective study.空腹血糖升高增加非糖尿病女性急性心肌梗死患者的院内死亡风险:一项回顾性研究。
Int J Endocrinol. 2014;2014:745093. doi: 10.1155/2014/745093. Epub 2014 Jul 14.
6
Admission hyperglycemia predicts poorer short- and long-term outcomes after primary percutaneous coronary intervention for ST-elevation myocardial infarction.入院高血糖预示着 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗后的短期和长期预后较差。
J Diabetes Investig. 2014 Feb 12;5(1):80-6. doi: 10.1111/jdi.12113. Epub 2013 Jun 17.
7
Acute insulin resistance in ST-segment elevation myocardial infarction in non-diabetic patients is associated with incomplete myocardial reperfusion and impaired coronary microcirculatory function.非糖尿病患者ST段抬高型心肌梗死中的急性胰岛素抵抗与心肌再灌注不完全及冠状动脉微循环功能受损有关。
Cardiovasc Diabetol. 2014 Apr 5;13:73. doi: 10.1186/1475-2840-13-73.
8
Population based absolute and relative survival to 1 year of people with diabetes following a myocardial infarction: a cohort study using hospital admissions data.基于人群的心肌梗死后糖尿病患者 1 年绝对和相对生存率:一项使用住院数据的队列研究。
BMC Public Health. 2010 Jun 14;10:338. doi: 10.1186/1471-2458-10-338.